The Effect of Propranolol and Thioridazine on Positive and Negative Symptoms of Schizophrenia
- 1 December 1985
- journal article
- research article
- Published by Royal College of Psychiatrists in The British Journal of Psychiatry
- Vol. 147 (6) , 623-630
- https://doi.org/10.1192/bjp.147.6.623
Abstract
Patients with chronic schizophrenia were treated with either propranolol (640 mg daily) or thioridazine (400 mg daily). In a double-blind study lasting five weeks, propranolol was superior to thioridazine on both psychiatrists' and nurses' ratings. Significant improvements were noted with propranolol in both positive (Type I) and negative (Type II) symptoms.This publication has 31 references indexed in Scilit:
- Propranolol in Schizophrenia: A Double Blind, Placebo Controlled Trial of Propranolol as an Adjunct to Neuroleptic MedicationThe British Journal of Psychiatry, 1983
- A Trial of Propranolol in Chronic SchizophreniaThe British Journal of Psychiatry, 1981
- Direct evidence for an interaction of β-adrenergic blockers with the 5-HT receptorNature, 1977
- The Influence of Family and Social Factors on the Course of Psychiatric IllnessThe British Journal of Psychiatry, 1976
- Association of high affinity stereospecific binding of 3H-propranolol to cerebral membranes with β adrenoceptorsNature, 1976
- Dopamine receptor binding: Differentiation of agonist and antagonist states with 3H-dopamine and 3H-haloperidolLife Sciences, 1975
- Role of fluphenazine decanoate in lessening the burden of chronic schizophrenics on the communityPsychological Medicine, 1973
- Relapse in Chronic Schizophrenics following Abrupt Withdrawal of Tranquilizing MedicationThe British Journal of Psychiatry, 1969
- Chlorpromazine and the Untreated Chronic Schizophrenic: A Long-Term TrialThe British Journal of Psychiatry, 1967
- Changes in the Prognosis of Functional Psychoses Since the Days of KraepelinThe British Journal of Psychiatry, 1967